Cancer BiologybioRxivPreprint
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53
Nour Sabiha Naji, Sergiu Paşca, Theodora Chatzilygeroudi…·Theodoros Karantanos
This study identifies CCRL2 as a driver of IFN-γ signaling in TP53-mutated AML with erythroid differentiation, linking it to disease progression and poor outcomes.
2 citations